NCT07104331
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07104331
Title SARC046: A Phase II Trial of Nab-Sirolimus in Patients With Progressing or Symptomatic Epithelioid Hemangioendothelioma
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Sarcoma Alliance for Research through Collaboration
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Stanford University RECRUITING Stanford California 94305 United States Details
University of Colorado NOT_YET_RECRUITING Aurora Colorado 80203 United States Details
Brigham and Women's Hospital NOT_YET_RECRUITING Boston Massachusetts 02115 United States Details
Dana-Farber Cancer Institute RECRUITING Boston Massachusetts 02215 United States Details
Washington University St. Louis RECRUITING St Louis Missouri 63130 United States Details
Sloan Kettering Institute for Cancer Research RECRUITING New York New York 10065 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field